Citation Impact
Citing Papers
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Equity of access to health care services:
2001 Standout
Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality
1997
A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
1990
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression
1979
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
How to perform a meta-analysis with R: a practical tutorial
2019 Standout
Chlorpromazine versus placebo for schizophrenia
2007
Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I
1996 Standout
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
1990
Psychedelics
2016 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Comorbidity of anxiety and depression in youth: Treatment implications.
1992
Role of GABAA Receptors in the Regulation of Sleep: Initial Sleep Responses to Peripherally Administered Modulators and Agonists
1999
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 Standout
5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
1995
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
1997
Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials
1999
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis
1996
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
2014
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
The Antiphospholipid Syndrome
2002 Standout
Effects of antidepressants on cognitive functions: A review
1995
"Cognitive Dysmetria" as an Integrative Theory of Schizophrenia: A Dysfunction in Cortical-Subcortical-Cerebellar Circuitry?
1998 Standout
Working-memory capacity and the control of attention: The contributions of goal neglect, response competition, and task set to Stroop interference.
2003 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Haloperidol versus placebo for schizophrenia
2001
Depression and Pain Comorbidity
2003 Standout
Dimensional overlap: Cognitive basis for stimulus-response compatibility--A model and taxonomy.
1990 Standout
Effects of the substituted (S)-3-phenylpiperidine (?)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity
1998 StandoutNobel
Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia
1990
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Fluvoxamine in the treatment of demented elderly patients: a double‐blind, placebo‐controlled study
1992
Recurrent miscarriage
2006 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Mild cognitive impairment as a diagnostic entity
2004 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
Cognitive Impairment in Individuals Currently Using Methamphetamine
2000
The Screen for Child Anxiety Related Emotional Disorders (SCARED): Scale Construction and Psychometric Characteristics
1997 Standout
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Effects of estrogen on the basal ganglia
1986
Chlorpromazine versus placebo for schizophrenia
2014
A Review of REM Sleep Deprivation
1975
Effect of Posture and Insulin Hypoglycemia on Catecholamine Excretion in the Newborn1
1960 StandoutNobel
Psychotic symptoms in borderline personality disorder
1986 Standout
Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients
1973
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Euthyroid hyperthyroxinemia
1983
Caffeine Consumption and Target Scanning Performance
1978
Clozapine, Chlorpromazine, and Placebo in Newly Hospitalized, Acutely Schizophrenic Patients
1979
Dopamine and the pharmacology of schizophrenia: The state of the evidence
1974
The effects of caffeine on physiological functions and mental performance
1984
The effects of low doses of caffeine on human performance and mood
1987 Standout
Haloperidol versus chlorpromazine for schizophrenia
2008
Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity.
1979
The Pharmacology of Tardive Dyskinesias
1973
A New Depression Scale Designed to be Sensitive to Change
1979 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
From motivation to action: Functional interface between the limbic system and the motor system
1980 Standout
A possible common mechanism of action of antidepressant treatments
1976
A Two-Year Longitudinal Study of Cognitive Function in Normal Aging and Alzheimer's Disease
1993
About Sleep's Role in Memory
2013 Standout
The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness
1987
Half a century of research on the Stroop effect: An integrative review.
1991 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Controlled and automatic human information processing: II. Perceptual learning, automatic attending and a general theory.
1977 Standout
Effect of Iprindole on Amine Uptake in Man
1972
Effects of imipramine on anxiety and hostility levels
1965
The Efficacy of Antidepressant Drugs
1974
Some current problems related to the mode of action of antidepressant drugs
1981 StandoutNobel
Haloperidol versus placebo for schizophrenia
2013
Roles of activation and inhibition in sex differences in cognitive abilities.
1968
Health and ergogenic effects of caffeine.
1989
Behavioural despair in rats: A new model sensitive to antidepressant treatments
1978 Standout
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Effect of Hypericum perforatum (St John's Wort) in Major Depressive Disorder
2002 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Sex differences in amphetamine-elicited rotational behavior and the lateralization of striatal dopamine in rats
1980
Plasma catechol amine and electroencephalographic responses to acute postural change
1959
Dopamine Receptors: From Structure to Function
1998 Standout
Industry sponsorship and research outcome
2017 Standout
Mode of action of antidepressant drugs
1978
The stroop color-word test: A review
1966 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Sex-role stereotypes and clinical judgments of mental health.
1970 Standout
Works of Lehmann He being referenced
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
1977
The psychopharmacological profile--a systematic approach to the interaction of drug effects and personality traits.
1961
Psychometric tests in evaluation of brain pathology, response to drugs.
1970
Pharmacotherapy of schizophrenia.
1966
Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
1974
New drugs in psychiatric therapy.
1961
Therapeutic results with chlorpromazine (largactil) in psychiatric conditions.
1955
Protrptyline in the treatment of chronic schizophrenic patients.
1970
Clinical observations with beta-endorphin injections.
1978
Differential screening of phrenotropic agents in man: psychophysiologio test data.
2000
Lack of indication for use of antiparkinson medication. A follow-up study.
1971
Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change.
1976
The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
1967
Pimozide in the treatment of chronic schizophrenic patients.
1970
The effect of hypnotics on rapid eye movement (REM).
1968
Proceedings: Thyrotropin releasing hormone in depression: clinical and endocrinological findings.
1976
Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
1968
A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.
1970
Psychological tests: practice effect in geriatric patients.
1968
The clinician's view of anxiety and depression.
1983
Comprehesiven clinical studies with thiothixene.
1975
Sex differences in long-term adverse effects of phenothiazines.
1974
Negative findings with megavitamins in schizophrenic patients: preliminary report.
1977
Effects of psychoactive drugs on conflict avoidance behavior in human subjects.
1971
A preliminary investigation of WY-3263 versus amitriptyline in depressions.
1968
Systematic clinical studies with trazodone: methodological aspects.
1973
Comparative pharmacotherapy of the aging psychotic patient.
1967